Overview of endpoints in atrial fibrillation studies

Area of Science:

• Cardiology
• Clinical Trials
• Medical Research Methodology

Background:

• The selection of endpoints in arrhythmia management trials is critical for assessing therapeutic effectiveness.
• Historically, maintaining sinus rhythm has been prioritized for atrial fibrillation, often treated as a primary goal.

Purpose of the Study:

• To critically evaluate the principles for selecting clinically relevant endpoints in arrhythmia management trials.
• To discuss the limitations of surrogate endpoints, such as sinus rhythm maintenance, and advocate for patient-centered outcomes.

Main Methods:

• Review of established principles for endpoint selection in clinical trials.
• Analysis of the validity and limitations of various endpoints, including surrogate markers and patient-reported outcomes.
• Discussion of methodological challenges in quantifying symptoms and quality of life.

Main Results:

• Maintenance of sinus rhythm is a surrogate endpoint and not always indicative of improved clinical outcomes, as demonstrated by the Cardiac Arrhythmia Suppression Trial.
• Clinical events are preferred endpoints but occur infrequently in atrial fibrillation.
• Patient-reported outcomes like symptoms and quality of life are valuable but require robust quantification methods.

Conclusions:

• Clinically relevant endpoints, closely aligned with therapeutic objectives, are paramount in arrhythmia trials.
• Surrogate endpoints like sinus rhythm or heart rate control may not accurately reflect clinical benefit and require further validation.
• Further research is needed to develop and validate reliable methods for assessing symptoms and quality of life to advance atrial fibrillation management.